<SEC-DOCUMENT>0001683168-22-006313.txt : 20220912
<SEC-HEADER>0001683168-22-006313.hdr.sgml : 20220912
<ACCEPTANCE-DATETIME>20220912135638
ACCESSION NUMBER:		0001683168-22-006313
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220912
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220912
DATE AS OF CHANGE:		20220912

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTRUSION INC
		CENTRAL INDEX KEY:			0000736012
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				751911917
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39608
		FILM NUMBER:		221238277

	BUSINESS ADDRESS:	
		STREET 1:		101 EAST PARK BLVD, SUITE 1200
		CITY:			PLANO
		STATE:			TX
		ZIP:			75074
		BUSINESS PHONE:		9722346400

	MAIL ADDRESS:	
		STREET 1:		101 EAST PARK BLVD, SUITE 1200
		CITY:			PLANO
		STATE:			TX
		ZIP:			75074

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTRUSION COM INC
		DATE OF NAME CHANGE:	20000601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ODS NETWORKS INC
		DATE OF NAME CHANGE:	19970507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OPTICAL DATA SYSTEMS INC
		DATE OF NAME CHANGE:	19950517
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>intrusion_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:INTZ="http://intrusion.com/20220912">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_INTZ_intrusion.com_20220912 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20220912_20220912 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0000736012 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityCentralIndexKey">0000736012</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="intz-20220912.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-09-12to2022-09-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-12</xbrli:startDate>
        <xbrli:endDate>2022-09-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">UNITED STATES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 12pt">FORM
<span id="xdx_901_edei--DocumentType_c20220912__20220912_zAzmj8NAyCo1"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CURRENT REPORT</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of
earliest event reported): <b><span id="xdx_908_edei--DocumentPeriodEndDate_c20220912__20220912_ziZkomEtO5Xh"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">September 12,
2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_909_edei--EntityRegistrantName_c20220912__20220912_zjwD6RnUT68e" style="font-size: 12pt"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityRegistrantName">INTRUSION
INC.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact Name of Registrant as Specified
in Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20220912__20220912_zKDr6VtHhSqi"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20220912__20220912_zHigLaeW69Zk"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityFileNumber">001-39608</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20220912__20220912_zNO2cSllbZqi"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityTaxIdentificationNumber">75-1911917</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction<br />
of Incorporation)</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File<br />
Number)</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer<br />
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 50%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20220912__20220912_z7L2a4wAchEd"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityAddressAddressLine1">101
    East Park Blvd</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20220912__20220912_zyO5x9P8o14a"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityAddressAddressLine2">Suite
    1200</ix:nonNumeric></span><br /> <span id="xdx_909_edei--EntityAddressCityOrTown_c20220912__20220912_zxcQhOcNevo9"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityAddressCityOrTown">Plano</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220912__20220912_zBOYclqBCAka"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 50%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20220912__20220912_zsGCL4oYQrGc"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:EntityAddressPostalZipCode">75074</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_908_edei--CityAreaCode_c20220912__20220912_zvgZ9WbhupG4"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:CityAreaCode">(972)</ix:nonNumeric></span> <span id="xdx_90E_edei--LocalPhoneNumber_c20220912__20220912_zv6rejod8qEd"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:LocalPhoneNumber">234-6400</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s Telephone Number,
Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 4.95pt"></td><td style="width: 17.95pt"><span style="font-family: Wingdings"><span id="xdx_90A_edei--WrittenCommunications_c20220912__20220912_zCiTuwR8L6Ri"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt:booleanfalse" name="dei:WrittenCommunications">o</ix:nonNumeric></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 4.95pt"></td><td style="width: 17.95pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20220912__20220912_zy6wm3n3IIsh"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt:booleanfalse" name="dei:SolicitingMaterial">o</ix:nonNumeric></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 4.95pt"></td><td style="width: 17.95pt"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20220912__20220912_zLryb8A5l0I6"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">o</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 4.95pt"></td><td style="width: 17.95pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20220912__20220912_z3xFQsZNzWn2"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">o</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20220912__20220912_ze7pkDupeDcj"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:Security12bTitle">Common Stock, $0.01 par value per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20220912__20220912_zzC1TZtpLnlk"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" name="dei:TradingSymbol">INTZ</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20220912__20220912_zLWnEMpb6lZh"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20220912__20220912_z89yfYG03k6j"><ix:nonNumeric contextRef="From2022-09-12to2022-09-12" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate by check mark if
the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.1pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 12, 2022, Intrusion Inc. (the &#8220;Company&#8221;) entered
into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain purchasers identified on the signature pages
to the Purchase Agreement (collectively, the &#8220;Purchasers&#8221;) pursuant to which, among other things, the Company agreed to issue
and sell to the Purchasers, in a registered direct offering (the &#8220;Offering&#8221;), an aggregate of 1,378,677 shares of its common
stock (the &#8220;Shares&#8221;), each of which is coupled with a warrant to purchase one share of common stock (the &#8220;Warrants&#8221;),
at an aggregate offering price of $4.29 per share and warrant. Wellington Shields &amp; Co. LLC acted as placement agent in the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Warrant will have an
exercise price of $5.22 per share of common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar
transactions, be exercisable from the date of issuance through the five-year anniversary of such date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
customary representations, warranties and agreements of the Company and the Purchasers, indemnification obligations of the Company, other
obligations of the parties and termination provisions. Pursuant to the Purchase Agreement and separate lock-up agreements, the Company
has agreed to certain restrictions on the issuance and sale of shares of the Company&#8217;s securities, and the Company&#8217;s directors
and officers have agreed to certain restrictions on the sale of the Company&#8217;s securities, in each case, for a period of 60 days
following the date of the Purchase Agreement, subject to certain exceptions.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company expects to deliver
the Shares and Warrants on or about September 14, 2022 (the &#8220;Closing Date&#8221;) other than the 419,580 Shares and related Warrants
that the Company expects to deliver on or before October&#160;28, 2022, in each case subject to satisfaction of certain conditions. The
Offering is expected to result in net proceeds to the Company of approximately $5.3 million, after deducting placement agent fees and
estimated offering expenses payable by the Company but without giving effect to any proceeds the Company may receive upon exercise of
the Warrants. The Company intends to use the net proceeds from the offering working capital and general corporate purposes, including
to fund any redemption repayments initiated by the holders under the Company&#8217;s existing promissory notes with Streeterville Capital,
LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Offering is being made
pursuant to the Company&#8217;s effective shelf registration statement that was declared effective by the Securities and Exchange Commission
(the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), on August 16, 2021 (File
No. 333- 258491), a base prospectus included as part of the registration statement, and a final prospectus supplement the Company expects
to file with the Commission pursuant to Rule 424(b) under the Securities Act. The Company is filing as Exhibit 5.1 to this Current Report
on Form 8-K an opinion of its counsel, Wilson Sonsini Goodrich &amp; Rosati, PC, relating to the legality of the issuance and sale of
the securities being offered in the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summaries of
the Purchase Agreement and the Warrants do not purport to be complete and are qualified in their entirety by reference to the full texts
of the form of Purchase Agreement and the form Warrant that are filed herewith as Exhibits 10.1 and 4.1, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="text-decoration: underline; font-size: 10pt"><b>Exhibit <br />
No.</b></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td><span style="font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="intrusion_ex0401.htm">Form of Warrant</a></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">5.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="intrusion_ex0501.htm"><span style="font-size: 10pt">Opinion of Wilson</span> <span style="font-size: 10pt">Sonsini Goodrich &amp; Rosati, Professional Corporation</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="intrusion_ex1001.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement
    between the Company and the Purchasers, dated September 12, 2022</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">23.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Consent of &#160;Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation (included in <a href="intrusion_ex0501.htm">Exhibit 5.1</a>)</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>INTRUSION INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Dated: September 12, 2022</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td><span style="font-size: 10pt">/s/ Anthony Scott</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid"><span style="font-size: 10pt">Anthony Scott</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">President and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LfspDHGXDhVxyhhDvC0uk+LWjLT+PZJvad0QQyAk53w5QszEhta6Q4bTsiqgxn7olEOosEVGc0bvyLe7DPys8KKtY2XcuP7AnDyDnknDhfL30XnXFpsM4nkkZSQTiNMsTaDci+Cr52Ra3aBxWnWgTAMl08AaneLX9KFWTzLUv8akI7LVZDJIwniS3yDjRMKB7upBfLVQFLkIZmMFYsN0G74xN+uoh1WHvc+yE/rv4APhCUke -->



</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>intrusion_ex0401.htm
<DESCRIPTION>COMMON STOCK PURCHASE WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>COMMON STOCK
PURCHASE WARRANT<BR>
INTRUSION INC.&nbsp;</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U></U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 15%">Warrant Shares:</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 85%">[&bull;]</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">Initial Exercise Date:</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">September 14, 2022</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">Issue Date: </TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">September 14, 2022</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS COMMON STOCK PURCHASE
WARRANT (the &ldquo;<B>Warrant</B>&rdquo;) certifies that, for value received, [&bull;] or its assigns (the &ldquo;<B>Holder</B>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<B>Initial Exercise Date</B>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on September 14, 2027
(the &ldquo;<B>Termination Date</B>&rdquo;) but not thereafter, to subscribe for and purchase from Intrusion Inc., a Delaware corporation
(the &ldquo;<B>Company</B>&rdquo;), up to [&bull;] shares (as subject to adjustment hereunder, the &ldquo;<B>Warrant Shares</B>&rdquo;)
of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in <U>Section 2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Section 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used and
not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;),
dated September 12, 2022, among the Company and the purchasers party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Section 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as Exhibit
A (the &ldquo;<B>Notice of Exercise</B>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in <U>Section 2(d)(i)</U>) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer unless the cashless
exercise procedure specified in <U>Section 2(c)</U> below is permitted and specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be $5.22, subject to adjustment hereunder
(the &ldquo;<B>Exercise Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(A) = as applicable: (i) the VWAP on the
Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to <U>Section 2(a)</U> on a day that is not a Trading Day or (2) both executed and delivered pursuant to <U>Section 2(a)</U>
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported
by Bloomberg L.P. (&ldquo;<B>Bloomberg</B>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to <U>Section
2(a)</U> or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and
such Notice of Exercise is both executed and delivered pursuant to <U>Section 2(a)</U> after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(B) = the Exercise Price of this Warrant,
as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(X) = the number of Warrant Shares that
would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash
exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary
to this <U>Section 2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bid Price</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)) or (b) in all other cases, the fair market value of a share of Common Stock as determined by
an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Day</B>&rdquo;
means any day on which the Trading Market is open for trading, including any day on which the Trading Market is open for trading for a
period of time less than the customary time; <I><U>provided</U></I>, that in the event that the shares of Common Stock are not listed
or quoted on a Trading Market, then Trading Day shall mean a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)) or (b) in all other cases, the fair market value of a share of Common Stock as
determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<B>DWAC</B>&rdquo;) if the Company is then a participant in
such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to the Holder or
(B) this Warrant is being exercised via cashless exercise, and otherwise by delivery in book-entry form in the name of the Holder or its
designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder
in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice
of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice
of Exercise, provided that, in either case, the Company&rsquo;s obligation to deliver the Warrant Shares may not be any earlier than one
(1) Trading Day after receipt by the Company of the aggregate Exercise Price (such date that delivery of the Warrant Shares is required
hereunder, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;). Upon delivery of the Notice of Exercise and (other than in the case
of a cashless exercise) the Exercise Price, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date a notice of uncertificated shares
with respect to the Warrant Shares is delivered. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to use commercially reasonable efforts to maintain a transfer agent that is a participant in the FAST program so long
as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B>Standard Settlement Period</B>&rdquo; means the standard
settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock
as in effect on the date of delivery of a duly executed Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">iii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section
2(d)(i)</U> by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">iv.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, to the extent allowable under applicable law, (A) pay in cash
to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the
shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was
required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to
such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to
the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with
respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">v.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall round down to the nearest whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">vi.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Charges, Taxes and Expenses</U>. The Company will, from time to time, promptly pay all taxes and charges that may be imposed
upon the Company in respect of the issuance or delivery of Warrant Shares, but the Company shall not be obligated to pay any transfer
taxes in respect of the Warrants or the Warrant Shares. The Company or the Transfer Agent, as applicable, shall not register any transfer
or issue or deliver any Warrant certificate(s) or Warrant Shares unless or until the Persons requesting the registration or issuance shall
have paid to the Company or the Transfer Agent for the account of the Company the amount of such tax, if any, or shall have established
to the reasonable satisfaction of the Company and the Transfer Agent that such tax, if any, has been paid. The Company shall pay all Transfer
Agent fees required for processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">vii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have
the right to exercise any portion of this Warrant, pursuant to <U>Section 2</U> or otherwise, to the extent that after giving effect to
such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall
include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this <U>Section
2(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is
in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
therewith. To the extent that the limitation contained in this <U>Section 2(e)</U> applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this <U>Section 2(e)</U>, in determining the number
of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<B>Beneficial
Ownership Limitation</B>&rdquo; shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
<U>Section 2(e)</U>, <I><U>provided</U></I> that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant
held by the Holder and the provisions of this <U>Section 2(e)</U> shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this <U>Section 2(e)</U> to correct this paragraph (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership
Limitation, no alternate consideration or compensation shall be owed to the Holder; <I><U>provided</U>, <U>however</U>,</I> that the Warrant
shall remain outstanding, valid and in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Section 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable
in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise
of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the
number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this <U>Section 3(a)</U> shall become effective immediately after the
record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to <U>Section 3(a)</U> above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<I><U>provided</U></I>, <I><U>however</U></I>,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction), other than dividends or distributions
subject to Section 3(a) (a &ldquo;<B>Distribution</B>&rdquo;), other than a reclassification as to which Section 3(d) applies, then in
each such case, at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in
such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common
Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution
(<I><U>provided</U></I>, <I><U>however</U></I>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent)
and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant), the
number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and
any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Subject to the Company&rsquo;s option to redeem the Warrant in accordance with Section 5(b), the Company shall
cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents. Upon the occurrence
of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of
such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a
share, as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>,
the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable
effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock
of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date
as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for
securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; <I><U>provided</U></I>
that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice. To the extent that any notice provided pursuant to this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries (as determined by the Company in consultation with Company
Counsel), the Company shall promptly disclose such information with the Commission pursuant to a Current Report on Form 8-K. The Holder
shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event
triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time
during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by
the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Section 4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Transferability</U>. Subject to compliance with applicable securities laws, this Warrant and all rights hereunder (including,
without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto as
Exhibit B duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly
be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.
The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial Issue Date
of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the &ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Section 5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Redemption</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Redemption of Warrants for Cash</U>. The Company may, at its option, elect to redeem all, but not less than all, of the then-outstanding
Warrants at the aggregate Exercise Price therefor at any time following the one-year anniversary date of the Issue Date while any Warrants
remain outstanding, upon notice to the registered holders of the Warrants, as described in <U>Section 5(b)</U> below, <I><U>provided</U></I>
that (i) there is an effective registration statement registering, and the prospectus contained therein is available for, the issuance
of the Warrant Shares to the Holder, available throughout the 30-day Redemption Period (as defined below) and (ii) on the Trading Day
prior to the Election Date, the Common Stock shall have had an average VWAP over the 20 Trading Days preceding such date of not less than
$20.00 per share, as adjusted for any for any stock splits or recapitalization. For purposes of this <U>Section 5</U>, &ldquo;<B>Election
Date</B>&rdquo; means the date of the Company&rsquo;s election to redeem the Warrants under this <U>Section 5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Redemption of Warrants Upon Fundamental Transaction</U>. The Company may, at its option, elect to redeem all, but not less than
all, of the then-outstanding Warrants in connection with, and upon the closing of, a Fundamental Transaction, upon notice to the registered
holders of the Warrants, as described in <U>Section 5(c)</U> below. The consideration payable to the Holder upon a redemption effected
under this <U>Section 5(b)</U> shall be, at the Company&rsquo;s election, (i) the Alternate Consideration receivable as a result of such
Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to
such Fundamental Transaction (without regard to any limitation in <U>Section 2(e)</U> on the exercise of this Warrant) less the aggregate
amount of the Exercise Price for the Warrants being so redeemed, which Exercise Price may be paid in cash or by proportionally reducing
the Alternate Consideration to be received, or (ii) the cash value of the consideration payable under clause (i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Date Fixed for, and Notice of, Redemption</U>. In the event the Company shall elect to redeem all of the Warrants pursuant to
<U>Section 5(a)</U>, the Company shall fix a date for the redemption (the &ldquo;<B>Redemption Date</B>&rdquo;), which date shall be no
later than 60 days after the Election Date. In the event the Company shall elect to redeem all of the Warrants pursuant to <U>Section
5(b)</U>, the Redemption Date shall be the closing date of the Fundamental Transaction. In either case, notice of redemption shall be
delivered by the Company in accordance with <U>Section 6(h)</U> not less than 30 days prior to the Redemption Date (the &ldquo;<B>30-day
Redemption Period</B>&rdquo;) to the registered holders of the Warrants to be redeemed at their last addresses as they shall appear on
the Warrant Register of the Company. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly
given whether or not the registered holder received such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exercise After Notice of Redemption</U>. The Warrants may be exercised for cash at any time after notice of redemption shall
have been given by the Company pursuant to <U>Section 5(c)</U> and prior to the Redemption Date. On and after the Redemption Date, the
record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Section 6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>, except
as expressly set forth in <U>Section 3</U>. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to <U>Section 2(c)</U> or to receive cash payments pursuant to <U>Section 2(d)(i)</U> and <U>Section 2(d)(iv)</U>, in no event
shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and in case of loss, theft or destruction, of indemnity
or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender
and cancellation of such Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor and dated as of such cancellation,
in lieu of such Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Except and to the extent as
waived or consented to by the Holder or in connection with a Fundamental Transaction, the Company shall not amend its certificate of incorporation
in a manner that would impact the Company&rsquo;s ability to perform its obligations under this Warrant. The Company also shall (i) not
increase the par value of any Warrant Shares above the Exercise Price and (ii) use commercially reasonable efforts to obtain all authorizations,
exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable
or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
may have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be
mailed (registered or certified mail, return receipt requested), personally delivered or sent by email transmission and confirmed and
shall be deemed given when so delivered or sent via email and confirmed or if mailed, two (2) days after such mailing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">if to the Company, to:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="text-align: justify">Intrusion Inc.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="text-align: justify">101 East Park Blvd, Suite 1200</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="text-align: justify">Plano, TX 75074</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="text-align: justify">Attention: Kimberly Pinson, Chief Financial Officer</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"></TD><TD STYLE="text-align: justify">Email: kimberly.pinson@intrusion.com</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">if to the Holder, at such address or other contact information delivered by the Holder to Company or as
is on the books and records of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>********************</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none"><I><U>(Signature
Page Follows)</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none"></FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal; text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B>INTRUSION INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B><BR>
</B>By:______________________________________<B><BR>
</B>Name: Anthony Scott</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">Title: President and Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>EXHIBIT A</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>&nbsp;</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>NOTICE OF EXERCISE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: <B>INTRUSION INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">[ ] in lawful money of the United States,
payable to the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">[ ] if permitted, the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Investing Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">__________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U><BR>
</U><I>Signature of Authorized Signatory of Investing Entity: </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 319.5pt"><U><BR>
</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 319.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">__________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><U><BR>
</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">__________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 319.5pt"><U><BR>
</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">__________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>EXHIBIT B</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal"><I><U>ASSIGNMENT
FORM</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%; text-align: left">Name: </TD>
    <TD STYLE="width: 48%; text-align: left">____________________________________<U></U></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Address: </TD>
    <TD STYLE="text-align: left">____________________________________<U> </U></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Phone Number: </TD>
    <TD STYLE="text-align: left">____________________________________<U></U></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Email Address: </TD>
    <TD STYLE="text-align: left">____________________________________<U></U></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Dated:&nbsp;&nbsp;_______________ ___, ________</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Holder&rsquo;s Signature:&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">____________________________________<U></U></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Holder&rsquo;s Address:&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">____________________________________<U></U></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>intrusion_ex0501.htm
<DESCRIPTION>OPINION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_001.gif" ALT="" STYLE="height: 48px; width: 128px"></FONT></TD>
    <TD STYLE="width: 51%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt">Wilson Sonsini Goodrich &amp; Rosati<BR>
    Professional Corporation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt">900 South Capital of Texas Highway<BR>
    Las Cimas IV, Fifth Floor<BR>
    Austin, Texas 78746-5546</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt">o: 512.338.5400<BR>
    f: 512.338.5499</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 120.75pt; text-align: right">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">September 12, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intrusion Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101 East Park Blvd, Suite 1200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Plano, Texas 75074</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 2pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 20pt; text-align: left">Re:</TD><TD STYLE="text-align: justify">Registration Statement on Form S-3</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to
Intrusion Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), in connection with the registration of the offer and
sale of (a) up to 1,378,677 shares (the &ldquo;<B><I>Shares</I></B>&rdquo;) of the Company&rsquo;s common stock, $0.01 par value per
share (&ldquo;<B><I>Common Stock</I></B>&rdquo;), (b) warrants to purchase up to 1,378,677 shares of Common Stock (the &ldquo;<B><I>Warrants</I></B>&rdquo;)
and (c) 1,378,677 shares of Common Stock issuable upon exercise of the Warrants (the &ldquo;<B><I>Warrant Shares</I></B>&rdquo; and,
together with the Shares and the Warrants, the &ldquo;<B><I>Securities</I></B>&rdquo;), pursuant to the Company&rsquo;s Registration Statement
on Form S-3 (File No. 333-258491) initially filed on August 5, 2021 and declared effective by the Securities and Exchange Commission (the
&ldquo;<B><I>Commission</I></B>&rdquo;) on August 16, 2021 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offering and sale of the
Securities are being made pursuant to the Securities Purchase Agreement (the &ldquo;<B><I>Securities Purchase Agreement</I></B>&rdquo;),
dated as of September 12, 2022, by and among the Company and the purchasers identified in the signature pages thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have examined copies of
the Securities Purchase Agreement, the form of Warrant, the Registration Statement, the base prospectus that forms a part thereof (the
&ldquo;<B><I>Base Prospectus</I></B>&rdquo;) as supplemented by the prospectus supplement to be dated September 12, 2022, in the form
filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations, together with the documents or portions thereof incorporated
by reference therein, as modified or superseded as described therein (the &ldquo;<B><I>Prospectus Supplement</I></B>&rdquo; and, together
with the Base Prospectus, the &ldquo;<B><I>Prospectus</I></B>&rdquo;). We have also examined instruments, documents and records that we
deemed relevant and necessary for the basis of our opinion hereinafter expressed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In such examination, we have
assumed (i) the authenticity of original documents and the genuineness of all signatures, (ii) the conformity to the originals of all
documents submitted to us as copies, (iii) the truth, accuracy, and completeness of the information, representations and warranties contained
in the records, documents, instruments and certificates we have reviewed; and (iv) the legal capacity of all natural persons. As to any
facts material to the opinions expressed herein that were not independently established or verified, we have relied upon oral or written
statements and representations of officers and other representatives of the Company. In making our examination of documents executed or
to be executed, we have assumed that the counterparties thereto, excluding the Company, have been duly incorporated or organized and are,
and will continue to be, validly existing and in good standing, and have or will have the requisite legal status and legal capacity under
the laws of their respective jurisdictions of incorporation or organization and had or will have the power, corporate or other, to enter
into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and
execution and delivery by such parties of such documents and, except as expressly set forth in the paragraphs below, the validity and
binding effect thereof on such parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon and subject to
the foregoing qualifications, assumptions and limitations and the further limitations set out below, we are of the opinion that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The Shares have been duly authorized by the Company and, when issued and delivered by the Company against
payment therefor in accordance with the terms of and in the manner contemplated by the Securities Purchase Agreement and the Prospectus,
will be validly issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The Warrants have been duly authorized by the Company and, when issued and delivered by the Company against
payment therefor in accordance with the terms of the Securities Purchase Agreement, will constitute valid and binding obligations of the
Company<FONT STYLE="background-color: white">, enforceable against the Company in accordance with their terms</FONT>; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Warrant Shares <FONT STYLE="background-color: white">have been duly authorized by the Company and,
when issued and delivered by the Company against payment of the exercise price therefor in accordance with the terms of the Warrants,</FONT>
will have been validly issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We express no opinion as to
the laws of any other jurisdiction other than the federal laws of the United States of America and the General Corporation Law of the
State of Delaware and, solely as to the Warrants constituting valid and binding obligations of the Company, the laws of the State of New
York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our opinion that any document
is legal, valid, binding and enforceable is qualified as to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">limitations imposed by bankruptcy, insolvency, reorganization, arrangement, fraudulent transfer, moratorium
or other similar laws relating to or affecting the rights of creditors generally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">rights to indemnification and contribution, which may be limited by applicable law or equitable principles;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">the effect of general principles of equity, including without limitation concepts of materiality, reasonableness,
good faith and fair dealing, and the possible unavailability of specific performance or injunctive relief and limitation of rights of
acceleration, regardless of whether such enforceability is considered in a proceeding in equity or at law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we express no
opinion as to whether a state court outside of the State of New York or a federal court of the United States would give effect to the
choice of New York law provided for in the Warrants. For purposes of our opinion in paragraph 2, we have assumed the Exercise Price (as
defined in the Warrants) will not be adjusted to an amount below the par value per share of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the use
of this opinion as an exhibit to the Company&rsquo;s Current Report on Form 8-K filed on or about the date hereof, for incorporation by
reference into the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent
is required under Section 7 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">/s/ Wilson Sonsini Goodrich &amp; Rosati,
P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><B>WILSON SONSINI GOODRICH &amp; ROSATI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">Professional Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>intrusion_ex1001.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>SECURITIES PURCHASE
AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<B>Agreement</B>&rdquo;) is dated as of September 12, 2022 and is between Intrusion Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<B>Purchaser</B>&rdquo;
and collectively the &ldquo;<B>Purchasers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, subject to
the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as
defined below) as to the Shares and the Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally
and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE, IN CONSIDERATION</B>
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">ARTICLE
I.</FONT><BR>
<BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this <U>Section 1.1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Authorization</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(kk)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Board of Directors</B>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <I><U>provided</U></I>, <I><U>however</U></I>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing</B>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Date</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commission</B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock</B>&rdquo;
means the shares of common stock of the Company, $0.01 par value per share and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock Equivalents</B>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Counsel</B>&rdquo;
means Wilson Sonsini Goodrich &amp; Rosati, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>EDGAR</B>&rdquo;
means the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval System.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Environmental Law</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Evaluation Date</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(t)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exempt Issuance</B>&rdquo;
means the issuance of (a) shares of Common Stock, options or other security-based compensation to employees, officers, directors, consultants
or advisors of the Company pursuant to any stock option plan, omnibus long-term incentive plan or similar arrangement duly adopted for
such purpose, by a majority of the non-employee members of the Board of Directors, or a majority of the members of a committee of non-employee
directors established for such purpose; <I><U>provided</U></I>, that any issuance of securities to consultants or advisors pursuant to
<U>clause (a)</U> above that are not issued pursuant to a Form S-8 shall be issued as &ldquo;restricted securities&rdquo; (as defined
in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the 60 day period following the Closing Date; (b) securities issued or issuable upon the exercise, exchange of or conversion of
any Securities issued hereunder and/or currently outstanding securities that are exercisable or exchangeable for, redeemable for or convertible
into shares of Common Stock, provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection
with stock splits, combinations or other equitable adjustments) or to extend the term of such securities; (c) securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, <I><U>provided</U></I>
that such securities shall be issued as &quot;restricted securities&quot; (as defined in Rule 144) and carry no registration rights that
require or permit the filing of any registration statement in connection therewith during the 60-day period following the Closing Date,
and <I><U>provided further</U></I> that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and
shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities; and (d) shares of Common Stock, restricted stock units (RSUs) or options in connection with existing employment contracts
and the hire of new executive officers/consultants of the Company; <I><U>provided</U></I>, that any issuance of securities to consultants
pursuant to this <U>clause (d)</U> that are not issued pursuant to a Form S-8 shall be issued as &ldquo;restricted securities&rdquo; (as
defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the 60-day period following the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>FCPA</B>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>GAAP</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(j)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Hazardous Substances</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Intellectual Property
Rights</B>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(r)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Issuer Free Writing
Prospectus</B>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(f)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IT Systems</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Lien</B>&rdquo;
means a lien, charge, mortgage, pledge, security interest, claim, right of first refusal, pre-emptive right, or other encumbrance of any
kind whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Lock-Up Agreement</B>&rdquo;
means the Lock-Up Agreements, each dated as of the Closing Date, by and between the Company and (i) the members of the board of directors
of the Company and (ii) the executive officers of the Company, in substantially the form of <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Adverse
Effect</B>&rdquo; shall have the meaning assigned to such term in <U>Section 3.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Permits</B>&rdquo;
shall have the meaning assigned to such term in <U>Section 3.1(q)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Money Laundering
Laws</B>&rdquo; shall have the meaning assigned to such term in <U>Section 3.1(hh)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offering</B>&rdquo;
means the offering of the Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Personal Data</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Per Share and Warrant
Purchase Price</B>&rdquo; equals $4.29, of which $4.17 is allocable to each share of Common Stock being sold hereunder, and of which $0.12
is allocable to each Warrant being purchased hereunder, subject to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Placement Agent</B>&rdquo;
means Wellington Shields &amp; Co. LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceeding</B>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such
as a deposition) pending or, to the Company&rsquo;s knowledge, threatened in writing against or affecting the Company, any Subsidiary
or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prospectus</B>&rdquo;
means the final base prospectus filed as part of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prospectus Supplement</B>&rdquo;
means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered
by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchaser Party</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 4.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration Statement</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(f)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Required Approvals</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sanctions</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(ff)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC Reports</B>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(j)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities</B>&rdquo;
means for each Purchaser, the Shares and the Warrants purchased pursuant to this Agreement. Each Security will be comprised of one Share
and a Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Act</B>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Shares</B>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Short Sales</B>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Streeterville Notes</B>&rdquo;
means that certain Promissory Note #1, dated March 10, 2022, by and between the Company and Streeterville Capital, LLC and that certain
Promissory Note #2, dated June 8, 2022, by and between the Company and Streeterville Capital, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subscription Amount</B>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
and &ldquo;<B>Subsidiaries</B>&rdquo; shall have the meanings ascribed to such terms in <U>Section 3.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Day</B>&rdquo;
means a day on which the Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means the Nasdaq Capital Market (or any nationally recognized successor thereto); <I><U>provided</U></I>, <I><U>however</U></I>, that
in the event the Company&rsquo;s Common Stock is ever listed or traded on The Nasdaq Global Market, The Nasdaq Global Select Market, the
New York Stock Exchange, the NYSE American, the NYSE Arca, the OTC Pink Market, or the OTCQX or the OTCQB operated by the OTC Markets
Group, Inc. (or any nationally recognized successor to any of the foregoing), then the &ldquo;Trading Market&rdquo; shall mean such other
market or exchange on which the Company&rsquo;s Common Stock is then listed or traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Documents</B>&rdquo;
means this Agreement, the Warrants, the Lock-Up Agreements and the Placement Agency Agreement dated on or about the date hereof between
the Placement Agent and the Company, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transfer Agent</B>&rdquo;
means Computershare Limited, the current transfer agent of the Company, with offices at 801 US Highway 1, North Palm Beach, FL 33408,
and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrants</B>&rdquo;
means the warrants to purchase shares of Common Stock of the Company at an exercise price of $5.22 per share and which shall be immediately
exercisable after issuance and have a term of five years after issuance, in each case in accordance with the terms set forth in <U>Exhibit
B</U>. The Warrants offered and sold to each Purchaser hereunder will entitle such Purchaser to purchase a number of Warrant Shares equal
to 100% of the number of Shares being purchased by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrant Shares</B>&rdquo;
means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">ARTICLE
II.</FONT><BR>
<BR>
PURCHASE AND SALE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Closing</U>. On the second Business Day following the execution of this Agreement, or the third Business Day if this Agreement
is executed after on or after 4:30 p.m., Eastern Time (the &ldquo;<B>Closing Date</B>&rdquo;), upon satisfaction of the covenants and
conditions set forth in <U>Sections 2.2</U> and <U>2.3</U>, upon the terms and subject to the conditions set forth herein, the Company
agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $5,914,524.33 of Securities, at
the Per Share and Warrant Purchase Price. The Company shall deliver to each Purchaser its Shares and Warrants, and the Company and each
Purchaser shall deliver the other items set forth in <U>Section 2.2</U> deliverable at the Closing. Upon satisfaction of the covenants
and conditions set forth in <U>Sections 2.2</U> and <U>2.3</U>, the Closing shall occur at the offices of McGuireWoods LLP, 1251 Avenue
of the Americas, 20<SUP>th</SUP> Floor, New York, New York 10020, or such other location as the parties shall mutually agree or by electronic
exchange of executed documents. Payment of each Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed
by such Purchaser for the Securities shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order
of the Company upon delivery of the Shares in book-entry form either through the facilities of the Depository Trust Company or otherwise
on the books and records of the Transfer Agent and the Warrants in originally signed form. The Shares and Warrants shall be registered
in such name or names and in such authorized denominations as indicated by the Purchasers in the signature pages to this Agreement. Notwithstanding
the foregoing, the potential Purchaser named in <U>Schedule A</U> to this Agreement may delay delivery of $1.8 million of his $2.0 million
Subscription Amount, and the Company may then correspondingly delay delivery of $1.8 million of the Securities owed to such Purchaser,
to a date that is no later than October 28, 2022. If such Purchaser elects to delay such delivery, the subsequent closing shall be on
the same terms and subject to the same conditions as applied on the Closing Date, modified as appropriate for the delayed and limited
nature, except that the deliverables contemplated by <U>Section 2.2(a)(ii)</U>, <U>(viii)</U> and <U>(ix)</U> shall not be required on
such closing date and the closing conditions set forth <U>Section 2.3(b)</U> shall not apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>On or prior to the Closing Date, except with respect to the Purchaser identified on <U>Schedule A</U>, the Company shall deliver
or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>this Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a legal opinion of Company Counsel, in a form reasonably acceptable to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via
The Depository Trust Company Deposit or Withdrawal at Custodian system (DWAC), or otherwise on the books and records of the Transfer Agent,
Shares equal to such Purchaser&rsquo;s Subscription Amount <U>less</U> the aggregate Per Warrant Purchase Price <U>divided</U> by the
Per Share Purchase Price, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a Warrant registered in the name of such Purchaser to purchase up to the number of shares of Common Stock equal to 100% of such
Purchaser&rsquo;s Shares, subject to adjustment as set forth therein, a PDF copy of which shall be provided to such Purchaser on the Closing
Date, with original Warrant to be delivered to applicable Purchaser within five (5) business days of Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Lock-up Agreements, executed by (x) the members of the board of directors of the Company and (y) the executive officers of the
Company and countersigned by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>an Officer&rsquo;s Certificate, in form and substance satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>a Secretary&rsquo;s Certificate, in form and substance satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>On or prior to the Closing Date, except with respect to the Purchaser identified on <U>Schedule A</U>, each Purchaser shall deliver
or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>this Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such Purchaser&rsquo;s Subscription Amount, which shall be paid by wire transfer in Federal (same day) funds, payable to the order
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (except
to the extent a representation or warranty speaks as of a specific date, in which case such representation or warranty shall be accurate
as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>all Required Approvals shall have been obtained; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the delivery by each Purchaser of the items set forth in <U>Section 2.2(b)</U> of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except with respect to the Purchaser identified on <U>Schedule A</U>, the respective obligations of the Purchasers hereunder in
connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Company contained herein (except to
the extent a representation or warranty speaks as of a specific date, in which case such representation or warranty shall be accurate
as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the delivery by the Company of the items set forth in <U>Section 2.2(a)</U> of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>on the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Trading Market, and trading
in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been
declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of
hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial
market which, in each case, in the reasonable judgment of the Placement Agent, makes it impracticable or inadvisable to purchase the Securities
at the Closing.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">ARTICLE
III.</FONT><BR>
<BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to
each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on Exhibit 21 to the Company&rsquo;s
most recently filed Annual Report on Form 10-K other than Intrusion Ltd., which has been dissolved (each entity other than Intrusion Ltd.,
a &ldquo;<B>Subsidiary</B>&rdquo;, and collectively, the &ldquo;<B>Subsidiaries</B>&rdquo;). The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. There are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any capital stock of any Subsidiary, or contracts, commitments, understandings
or arrangements by which any Subsidiary is or may become bound to issue capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Organization and Qualification</U>. The Company and each of the Subsidiaries has been duly organized and validly exists as a
corporation, limited partnership or company in good standing (or the foreign equivalent thereof, if any) under the laws of its jurisdiction
of organization. The Company and each of the Subsidiaries is duly qualified to do business and is in good standing as a foreign or extra-provincial
corporation, partnership, company or limited liability company in each jurisdiction in which the character or location of its properties
(owned, leased or licensed) or the nature or conduct of its business makes such qualification necessary, except for those failures to
be so qualified or in good standing which (individually and in the aggregate) would not have a Material Adverse Effect. To the knowledge
of the Company, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit
or curtail such power and authority or qualification. Neither the Company nor any Subsidiary is in violation or default of any of the
provisions of its certificate or articles of incorporation, bylaws or other organizational or charter documents. The term &ldquo;<B>Material
Adverse Effect</B>&rdquo; means an effect, change, event or occurrence that, alone or in conjunction with any other or others: (i) has
or would reasonably be expected to have a material adverse effect on the business, general affairs, management, condition (financial or
otherwise), results of operations, stockholders&rsquo; equity, properties or prospects of the Company and the Subsidiaries, taken as a
whole or (ii) the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document;
<I><U>provided</U></I> that a change in the market price or trading volume of the Common Stock alone shall not be deemed, in and of itself,
to constitute a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
the Company is a party has been (or upon delivery will have been) duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and
thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or
articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority, to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which
any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of <U>clauses (ii)</U> and <U>(iii)</U>,
such as would not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fi</FONT><U>lings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state (including state blue sky laws), local or other governmental
authority or other Person in connection with the execution, delivery and performance by the Company of this Agreement and the other Transaction
Documents, including with respect to the issuance and sale of the Securities, other than: (i) the filings required pursuant to <U>Section
4.5</U> of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to each applicable
Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iv) such
filings as are required to be made under applicable state securities laws or by the bylaws and rules of the Financial Industry Regulatory
Authority (collectively, the &ldquo;<B>Required Approvals</B>&rdquo;) and (v) any such consents, waivers, authorizations that have been,
or prior to the Closing Date will be, obtained by the Company or as would not have or reasonably be expected to result in a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Issuance of the Shares and Warrant Shares; Qualification; Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly
and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Warrants, when issued and paid
for in accordance with the applicable Transaction Documents, will be valid and binding obligations of the Company, enforceable against
the Company in accordance with their terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors&rsquo; rights generally and by general equitable principles and (ii) the indemnification
provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof.
The Warrant Shares are duly authorized and, when issued and paid for in accordance with the terms of the Warrants, will be validly issued,
fully paid and non-assessable. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to this Agreement including with respect to issuance of the Warrant Shares upon exercise of the Warrants. As of
the Closing, the Company shall have reserved from its duly authorized capital stock not less than 100% of the maximum number of shares
of Common Stock issuable upon exercise of the Warrants (without taking into account any limitations on the exercise of the Warrants set
forth in the Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company has prepared and filed with the Commission a registration statement under the Securities Act on Form S-3 (File No.
333-258491) providing for the offer and sale, from time to time, of up to $100,000,000 of the Company&rsquo;s securities (the &ldquo;<B>Registration
Statement</B>&rdquo;). The Registration Statement was declared effective under the Securities Act on August 16, 2021. The Company was
at the time of the filing of the Registration Statement eligible to use Form S-3.&nbsp;The Company is eligible to use Form S-3 under the
Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being sold pursuant
to this offering and during the twelve (12) calendar months prior to this offering, as set forth in General Instruction I.B.6 of Form
S-3. No stop order suspending the effectiveness of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus has
been issued under the Securities Act and no proceedings for that purpose have been instituted or are pending or, to the knowledge of the
Company, are contemplated by the Commission and any request on the part of the Commission for additional information has been complied
with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any &ldquo;issuer free writing
prospectus&rdquo; (as defined in Rule 433 under the Securities Act) relating to the Securities is hereafter referred to as an &ldquo;<B>Issuer
Free Writing Prospectus</B>&rdquo;. Any reference herein to the Prospectus or the Prospectus Supplement shall be deemed to refer to and
include the documents incorporated by reference therein as of the date of filing thereof; and any reference herein to any &ldquo;amendment&rdquo;
or &ldquo;supplement&rdquo; with respect to any of the Prospectus or the Prospectus Supplement shall be deemed to refer to and include
(i) the filing of any document with the Commission incorporated or deemed to be incorporated therein by reference after the date of filing
of such Prospectus or Prospectus Supplement and (ii) any such document so filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All references in this Agreement
to the Registration Statement, the Prospectus, or the Prospectus Supplement, or any Issuer Free Writing Prospectus, or any amendments
or supplements to any of the foregoing, shall be deemed to include any copy thereof filed with the Commission on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Securities Act Compliance</U>. The Registration Statement and the Prospectus comply, and the Prospectus Supplement and any further
amendments or supplements to the Registration Statement, the Prospectus or the Prospectus Supplement will comply, in all material respects
with the applicable provisions of the Securities Act. Each part of the Registration Statement, when such part was declared effective,
did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading. The Prospectus and the Prospectus Supplement and any amendments or supplements thereto, at
the time the Prospectus, the Prospectus Supplement or any such amendment or supplement to either of the foregoing was issued and at the
Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act, including, but not limited
to, the disclosure obligations required under Item 404(a) of Regulation S-K. The Prospectus and the Prospectus Supplement, as of their
respective filing dates, and any amendments or supplements thereto, did not and will not contain an untrue statement of a material fact
or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity
with, information furnished to the Company by the Placement Agent specifically for use in the preparation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Capitalization</U>. The equity capitalization of the Company as of June 30, 2022 is as set forth in the SEC Reports. All of
the issued and outstanding shares of Common Stock are duly authorized, validly issued, fully paid and non-assessable and have been duly
and validly authorized and issued in compliance with all federal and state securities laws and not in violation of or subject to any preemptive
or similar right that entitles any person to acquire from the Company any Common Stock or Common Stock Equivalent, except for such rights
as may have been fully satisfied or waived prior to the date hereof. Except as a result of the purchase and sale of the Securities and
as described in the Registration Statement, the Prospectus and the Prospectus Supplement, the Company has no outstanding options, warrants,
scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Common Stock, or contracts, commitments,
understandings or arrangements by which the Company is or may become bound to issue additional Common Stock or Common Stock Equivalents.
No Person has any right of first refusal, pre-emptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents, except for which waivers in full have been obtained by the Company. The issuance and sale of
the Securities will not obligate the Company to issue Common Stock or other securities to any Person (other than the Purchasers) and will
not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such
securities. There are no outstanding securities or instruments of the Company with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company. Except as disclosed in the SEC Reports,
there are no outstanding securities or instruments of the Company that contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company is or may become bound to redeem a security of the Company.
There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock
to which the Company is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>SEC Reports</U>. Since January 1, 2021, the Company has filed all reports, schedules, forms, statements and other &lrm;documents
required to be filed by the Company under the Securities Act and Exchange &lrm;Act, including pursuant to Section 13(a) or 15(d) thereof
(the foregoing materials, &lrm;including the exhibits thereto and documents incorporated by reference therein, together &lrm;with the
Prospectus and the Prospectus Supplement, being collectively referred to &lrm;herein as the &ldquo;<B>SEC Reports</B>&rdquo;) on a timely
basis or has received a valid extension of such &lrm;time of filing and has filed any such SEC Reports prior to the expiration of any
such &lrm;extension. Since January 1, 2021, as of their respective dates, the SEC Reports complied in all material respects &lrm;with
the requirements of the Securities Act and the Exchange Act, as applicable, and the SEC Reports, taken on the whole, as of the date hereof
do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is not,
and has never been, an issuer identified in Rule 144(i)(1) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Financial Statements</U>. The consolidated financial statements, including the notes thereto, included or incorporated by reference
in the Registration Statement, the Prospectus and the Prospectus Supplement comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements
have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the
periods involved (&ldquo;<B>GAAP</B>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects
the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest consolidated financial statements
included in or incorporated by reference into the Registration Statement and the Prospectus, except as set forth in the Registration Statement
and the Prospectus, (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result
in a Material Adverse Effect, (ii) neither the Company nor any Subsidiary has incurred any liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting and (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance
of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects,
properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that has not been publicly disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Litigation</U>. Except as disclosed in the SEC Reports, there is no Proceeding which (i) adversely affects or challenges the
legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) would, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Proceeding involving a claim of violation of or liability under federal or state
securities laws or a claim of breach of fiduciary duty, which would result in a Material Adverse Effect. The Company has disclosed, in
the documents filed by the Company pursuant to Sections 12, 13, 14 or 15 of the Exchange Act and incorporated or deemed to be incorporated
by reference into the Prospectus, all such information that it is required to disclose in respect of any Proceeding pursuant to the requirements
of the Securities Act and the Exchange Act, as applicable. There has not been, and to the knowledge of the Company, there is not pending
or contemplated, any material investigation by the Commission involving the Company or any current or former director or officer of the
Company which is required to be disclosed in the SEC Reports that has not been so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company or any Subsidiary, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s
or its Subsidiaries&rsquo; employees is a member of a labor union that relates to such employee&rsquo;s relationship with the Company
or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement. To the knowledge
of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term
of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other
contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer
does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and
its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment
practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case of <U>clauses (i)</U>, <U>(ii)</U>
and <U>(iii)</U> as would not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Environmental Law</U>. There has been no storage, generation, transportation, handling, use, treatment, disposal, discharge,
emission, contamination, release or other activity involving any kind of hazardous, toxic or other wastes, pollutants, contaminants, petroleum
products or other hazardous or toxic substances, chemicals or materials (&ldquo;<B>Hazardous Substances</B>&rdquo;) by, due to, on behalf
of, or caused by the Company or any Subsidiary (or, to the Company&rsquo;s knowledge, any other entity for whose acts or omissions the
Company is or may be liable) upon any property now or previously owned, operated, used or leased by the Company or any Subsidiary, or
upon any other property, which would be a violation of or give rise to any liability under any applicable law, rule, regulation, order,
judgment, decree or permit, common law provision or other legally binding standard relating to pollution or protection of human health
and the environment (&ldquo;<B>Environmental Law</B>&rdquo;), except for violations and liabilities which, individually or in the aggregate,
would not have a Material Adverse Effect. There has been no disposal, discharge, emission contamination or other release of any kind at,
onto or from any such property or into the environment surrounding any such property of any Hazardous Substances with respect to which
the Company or any Subsidiary has knowledge, except as would not, individually or in the aggregate, have a Material Adverse Effect. There
is no pending or, to the best of the Company&rsquo;s knowledge, threatened administrative, regulatory or judicial action, claim or notice
of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any Subsidiary, except
as would not, individually or in the aggregate, have a Material Adverse Effect. No property of the Company or any Subsidiary is subject
to any Lien under any Environmental Law. Except as disclosed in the Prospectus, neither the Company nor any Subsidiary is subject to any
order, decree, agreement or other individualized legal requirement related to any Environmental Law, which, in any case (individually
or in the aggregate), would have a Material Adverse Effect. The Company and each Subsidiary are in compliance with all applicable federal,
state, local and Environmental Laws and each has all permits, authorizations and approvals required under any applicable Environmental
Laws and are each in compliance with their requirements, except for failures to comply or failures to obtain permits which, individually
or in the aggregate, would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, (ii) Liens for the payment of
federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material
respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect
(&ldquo;<B>Material Permits</B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to
the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have would have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of
this Agreement except as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has
received a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person and neither is aware of any facts which would form a reasonable basis for any such claim, except as would not have
or reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are
enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries
have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties and
to protect and maintain their Intellectual Property Rights, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. Except for violations that would not, individually or in the aggregate, have
or reasonably be expected to result in a Material Adverse Effect, none of the Intellectual Property Rights used by the Company or any
of its Subsidiaries in their respective businesses has been obtained or is being used by the Company or such Subsidiary in violation of
any contractual obligation binding on the Company or any of its subsidiaries in violation of the rights of any person. The consummation
of the transactions contemplated by this Agreement will not result in the loss or impairment of, or payment of, and additional amounts
with respect to, nor require the consent of, any other person regarding the Company&rsquo;s or any of its subsidiaries&rsquo; right to
own or use any of the Intellectual Property Rights as owned or used in the conduct of such party&rsquo;s business as currently conducted.
To the knowledge of the Company and its Subsidiaries, no employee of any of the Company or any of the Subsidiaries is the subject of any
pending claim or proceeding involving a violation of any term of any employment contract, invention disclosure agreement, patent disclosure
agreement, noncompetition agreement, non-solicitation agreement, nondisclosure agreement or restrictive covenant to or with a former employer,
where the basis of such violation relates to such employee&rsquo;s employment with the Company or the Subsidiaries or actions undertaken
by the employee while employed with the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as the Company reasonably believes are prudent and customary in the businesses in which the Company
and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage. Neither the Company nor any
Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries and their respective officers and directors
are in compliance, in all material respects, with the applicable provisions of the Sarbanes-Oxley Act of 2002, as amended. The Company
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company
in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified
in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company and the Subsidiaries as of applicable dates specified under the Exchange Act (such date, the &ldquo;<B>Evaluation
Date</B>&rdquo;). The Company presented in its most recently filed annual report on Form 10-K the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Except as set
forth in the Prospectus, since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and the Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and the Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain Fees</U>. Except for fees payable to the Placement Agent as will be as set forth in the Prospectus, no brokerage or
finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.
The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for
fees of a type contemplated in this <U>Section 3.1(u)</U> that may be due in connection with the transactions contemplated by the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Investment Company</U>. The Company is not, and immediately after receipt of payment for the Securities, will not be, required
to register as an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Registration Rights</U>. Except as disclosed in the SEC Reports, no Person has any right to cause the Company or any Subsidiary
&lrm;to effect the registration under the Securities Act of the public sale or resale of any &lrm;securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Listing and Maintenance Requirements</U>. The Company is subject to the reporting requirements of Section 13 of the Exchange
Act and files periodic reports with the SEC; the Common Stock is registered with the SEC under Section 12(b) of the Exchange Act. The
Company has taken no action designed to or which is likely to have the effect of terminating the registration of its Common Stock under
the Exchange Act nor has it received any notice from the Commission that the Commission is contemplating terminating such registration.
The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is
or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. The Company is in compliance in all material respects with all such listing and maintenance requirements. The Common Stock
is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the
Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection
with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets
exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on
its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company has no knowledge of any facts or circumstances which lead it to believe that it will
file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and
other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
to the extent that such taxes are not being contested in good faith and (iii) has set aside on its books provision reasonably adequate
for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. To the
knowledge of the Company, there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Foreign Corrupt Practices; Criminal Acts</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company, any
agent or other person acting on behalf of the Company or any Subsidiary, has in the past five (5) years (i) directly or indirectly, used
any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity,
(ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties
or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any
person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any
provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Accountants</U>. To the knowledge and belief of the Company, the Company&rsquo;s independent registered public accounting firm
(i) is a registered public accounting firm as required by the Exchange Act and (ii) will express its opinion with respect to the financial
statements to be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the
Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary
notwithstanding (except for <U>Sections 3.2(f)</U> and <U>4.14</U>), it is understood and acknowledged by the Company that: (i) none of
the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or
short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities
for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation,
Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may
negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities (in material compliance with applicable laws) at various times during the period that the Securities are outstanding,
and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at
and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities
do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases
of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any &ldquo;<B>Sanctions</B>,&rdquo; which
shall include but are not limited to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department
(&ldquo;<B>OFAC</B>&rdquo;) and the Company will not, directly or indirectly, use the proceeds of this Offering, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing
the activities of any person known by the Company to currently be subject to any Sanctions, including but not limited to U.S. sanctions
administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan or omnibus long-term
incentive plan was granted (i) in accordance with the terms of such plan in all material respects and (ii) with an exercise price at least
equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable
law. No stock option granted under the Company&rsquo;s stock option plan or omnibus long-term incentive plan has been backdated. The Company
has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise
knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company
or the Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Money Laundering</U>. The operations of the Company and its Subsidiaries are conducted in compliance with applicable financial
record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money
laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;), <FONT STYLE="font-family: Times New Roman, Times, Serif">except
where the failure to be in such compliance would not result in a Material Adverse Effect;</FONT> and no action, suit or proceeding by
or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to
the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT><U>Information Technology</U>. The Company&rsquo;s and the Subsidiaries&rsquo; information technology assets and equipment,
computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &ldquo;<B>IT Systems</B>&rdquo;)
operate and perform in all material respects as required in connection with the operation of the business of the Company and the Subsidiaries
as currently conducted. The Company and the Subsidiaries maintain commercially reasonable controls, policies, procedures, and safeguards
to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and all personal, personally identifiable, sensitive, confidential or regulated data (&ldquo;<B>Personal Data</B>&rdquo;) processed
and stored thereon, and to the knowledge of the Company, there have been no breaches, incidents, violations, outages, compromises or unauthorized
uses of or accesses to same, except for (i) those that have been remedied without material cost or liability or the duty to notify any
other person, nor any incidents under internal review or investigations relating to the same or (ii) <FONT STYLE="font-family: Times New Roman, Times, Serif">those
that would not, individually or in the aggregate, have a Material Adverse Effect</FONT>. The Company and the Subsidiaries are presently
in compliance in all material respects with all applicable laws or statutes and all applicable judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access,
misappropriation or modification, except for any such noncompliance that would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person that has been or will be paid
(directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Regulatory</U>. Except as described in the Registration Statement and the Prospectus, as applicable, the Company and its Subsidiaries
(i) have not received any notice from any court or arbitrator or governmental or regulatory authority or third party alleging or asserting
noncompliance with any laws or any licenses, exemptions, certificates, approvals, clearances, authorizations, permits, registrations and
supplements or amendments thereto required to conduct the Company&rsquo;s business as presently conducted (&ldquo;<B>Authorizations</B>&rdquo;);
(ii) possess all material Authorizations and such Authorizations are valid and in full force and effect and are not in violation of any
term of any such Authorizations; (iii) have not received any written notice that any court or arbitrator or governmental or regulatory
authority has taken, is taking or intends to take, action to limit, suspend, materially modify or revoke any Authorizations nor is any
such limitation, suspension, modification or revocation threatened; (iv) have filed, obtained, maintained or submitted all material reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Authorizations
and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete
and accurate on the date filed (or were corrected or supplemented by a subsequent submission); and (v) are not a party to any corporate
integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental
or regulatory authority, except in the case of each of <U>clauses (i)</U> through <U>(v)</U>, such as would not have or reasonably be
expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ll)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Material Agreements</U>. The agreements and documents described in the Registration Statement or Prospectus conform in all material
respects to the descriptions thereof contained or incorporated by reference therein and conformed in all material respects to the requirements
of the Securities Act or the Exchange Act, as applicable at the time filed, and were filed on a timely basis with the Commission; there
are no agreements or other documents required by the Securities Act and the rules and regulations thereunder to be described in the Prospectus
or to be filed with the Commission as exhibits to the Registration Statement or to be incorporated by reference in the Registration Statement
or Prospectus, that have not been so described or filed or incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which
it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof or thereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally; (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business. Such Purchaser is acquiring such Securities as principal for his, her or its own account and not with
a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&rsquo;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal
and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, either:
(i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii)
a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the reports filed with the Commission and has been afforded: (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the
offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its
financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort
or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees
that neither the Placement Agent, nor any Affiliate of the Placement Agent, has provided such Purchaser with any information or advice
with respect to the Securities nor is such information or advice necessary or desired. Such Purchaser further acknowledges that there
have been no representations, warranties, covenants and agreements made to such Purchaser by the Company or any of its officers or directors,
expressly or by implication, other than those representations, warranties, covenants and agreements included in this Agreement. Neither
the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the
Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need
not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent, nor any of its
Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Placement Agent, the Company or any other Person representing the Company
setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with
respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered
by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without
limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained
the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).
Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against,
or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability of, and/or
securing of, securities of the Company in order for such Purchaser (or its broker or other financial representative) to effect Short Sales
or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>General Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice
or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or
radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Non-Foreign Person</U>. Purchaser acknowledges that the Company must assess potential foreign ownership, control, or influence
related to potential investments into the Company, and the Purchaser represents that it is not a &ldquo;foreign person&rdquo; within the
meaning of Treasury Regulations Section 1.1445-2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the representations contained in this <U>Section 3.2</U> shall not modify, amend or affect such Purchaser&rsquo;s right to
rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained
in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the
consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein
shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect
Short Sales or similar transactions in the future.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">ARTICLE
IV.</FONT><BR>
<BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legends</U>. The Shares shall be issued free of restrictive legends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Warrant Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement
to cover the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued
pursuant to any such exercise shall be issued free of all restrictive legends. If at any time following the date hereof the Registration
Statement (or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise
available for the sale or resale of the Warrant Shares by the holders thereof, the Company shall promptly notify the holders of the Warrants
in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration
statement is effective again and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing
shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable
federal and state securities laws). The Company shall use commercially reasonable efforts to keep a registration statement (including
the Registration Statement) registering the issuance or resale of the Warrant Shares effective during the term of the Warrants or until
their earlier exercise or redemption in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Furnishing of Information</U>. Until the Warrants have expired, the Company covenants to timely file (or obtain extensions in
respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant
to the Exchange Act so long as the Company is then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that the Company believes would be integrated with the offer or sale of the Securities
for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of
such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Securities Laws Disclosure; Publicity</U>. The Company shall file with the Commission on or before the Closing Date a Current
Report on Form 8-K, including the required Transaction Documents as exhibits thereto. From and after the date of such filing, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or Affiliates in connection with
the transactions contemplated by the Transaction Documents. In addition, effective upon the date of such filing, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its Subsidiaries or any of their respective officers, directors, employees or Affiliates, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate. The Company shall not publicly disclose the name of any Purchaser, or include
the name of any Purchaser, in any filing with the Commission or any regulatory agency or Trading Market or in any press release, without
the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction
Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the
Company shall provide the Purchasers with prior notice of such disclosure permitted under this <U>clause (b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents, which shall be disclosed pursuant to <U>Section 4.5</U>, the Company covenants and agrees that neither it, nor
any of its officers, directors, employees or Affiliates, will provide any Purchaser or any Purchaser&rsquo;s agents or counsel with any
information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such
Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The
Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company. To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, employees or
Affiliates delivers any material, non-public information to a Purchaser in connection with the transactions contemplated by the Transaction
Documents without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty
of confidentiality to the Company, any of the Subsidiaries, or any of their respective officers, directors, employees or Affiliates, or
a duty to the Company, any of the Subsidiaries or any of their respective officers, directors, employees or Affiliates not to trade on
the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously file such material non-public information with the Commission pursuant to
a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Use
of Proceeds</U>. The Company expects to use the net proceeds from the sale of the Securities for working capital and general corporate
purposes, including to fund&nbsp;any&nbsp;redemption repayments initiated by the holders under the Streeterville Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Indemnification of Purchasers</U>. Subject to the provisions of this <U>Section 4.8</U>, the Company will indemnify and hold
each &lrm;Purchaser and its directors, officers, employees and affiliates (and &lrm;any other Persons with a functionally equivalent role
of a Person holding such titles &lrm;notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
&lrm;&lrm;(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), &lrm;and the directors, officers,
stockholders, agents, members, partners or employees (and any other &lrm;Persons with a functionally equivalent role of a Person holding
such titles notwithstanding a lack &lrm;of such title or any other title) of such controlling persons (each, a &ldquo;<B>Purchaser Party</B>&rdquo;)
harmless &lrm;from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and &lrm;expenses, including all
judgments, amounts paid in settlements, court costs and reasonable &lrm;attorneys&rsquo; fees and costs of investigation that any such
Purchaser Party may suffer or incur &lrm;caused by or based upon (a) any breach of any of the representations, warranties covenants or
agreements made by the &lrm;Company in this Agreement or in the other Transaction Documents or (b) any action instituted &lrm;against
the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any &lrm;stockholder of the Company who is not
an Affiliate of such Purchaser Party, with respect to any &lrm;of the transactions contemplated by the Transaction Documents (unless such
action is solely &lrm;based upon a material breach of such Purchaser Party&rsquo;s representations, warranties or covenants &lrm;under
the Transaction Documents or any agreements or understandings such Purchaser Party may &lrm;have with any such stockholder or any violations
by such Purchaser Party of state or federal &lrm;securities laws or any conduct by such Purchaser Party which is finally judicially determined
to &lrm;constitute fraud, gross negligence or willful misconduct). The Company will indemnify each &lrm;Purchaser Party, to the fullest
extent permitted by applicable law, from and against any and all &lrm;losses, claims, damages, liabilities, costs (including, without
limitation, reasonable attorneys&rsquo; fees) &lrm;and expenses, as incurred, caused by or based upon (i) any untrue or alleged untrue
statement of &lrm;a material fact contained in the Registration Statement or any amendment thereto, any Issuer &lrm;Free Writing Prospectus,
the Prospectus, the Prospectus Supplement or any amendment or supplement thereto, or caused by &lrm;or based upon any omission or alleged
omission of a material fact required to be stated therein or &lrm;necessary to make the statements therein (in the case of any prospectus
or supplement thereto, in &lrm;the light of the circumstances under which they were made) not misleading, except to the extent, &lrm;but
only to the extent, that such untrue statements or omissions are based solely upon information &lrm;regarding such Purchaser Party furnished
in writing to the Company by such Purchaser Party &lrm;expressly for use therein, or (ii) any violation or alleged violation by the Company
of the &lrm;Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder &lrm;in connection therewith&lrm;.
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and the Company shall assume the defense thereof with counsel of its own
choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such
action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party
except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing, (y) the Company has failed
after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion
of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in
which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company
will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company&rsquo;s
prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent that a loss, claim, damage or liability
is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such
Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this <U>Section 4.8</U> shall
be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or
are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and
keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the
Company to issue the Shares and the Warrant Shares pursuant to this Agreement and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation
of the Common Stock on the Nasdaq Capital Market, and prior to the Closing, the Company shall apply to list or quote all of the Shares
and, if issued, the Warrant Shares on the Nasdaq Capital Market and promptly secure the listing of all of the Shares and Warrant Shares
on the Nasdaq Capital Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading
Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary
to cause all of the Shares and, if issued, the Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.
The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market
and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading
Market. For so long as the Company maintains a listing or quotation of the Common Stock on a Trading Market, the Company agrees to maintain
the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation,
including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation
in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Lock-Up</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without
obtaining the prior consent of the Placement Agent, except to extend the term of the lock-up period and shall enforce the provisions of
each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement,
the Company shall promptly use its commercially reasonable efforts to seek specific performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Subsequent Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>From the date hereof until 60 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or file any registration statement
or any amendment or supplement thereto relating to the offering of any shares of capital stock of the Company or any securities convertible
into or exercisable or exchangeable for shares of capital stock of the Company (other than a registration statement on Form S-8), in each
case other than as contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding the foregoing, <U>Section 4.12(a)</U> shall not apply in respect of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>an Exempt Issuance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any offering of Common Stock and/or Common Stock Equivalents in which the Placement Agent is acting as lead or joint placement
agent or underwriter and shall not apply to issuances of shares of Common Stock for which the obligation to issue such shares has been
disclosed in the SEC Reports before the date hereof; <I><U>provided</U></I>, <I><U>however</U></I>, that such securities are issued as
&ldquo;restricted securities&rdquo; (as defined in Rule 144 of the Securities Act) and carry no registration rights that require or permit
the filing of any registration statement in connection therewith during the prohibition period in <U>Section 4.12(a)</U> or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Common Stock offered and sold pursuant to the Company&rsquo;s sales agreement with B. Riley Securities, Inc. in connection with
the Company&rsquo;s existing &ldquo;at the market offering,&rdquo; as described in the prospectus supplements filed by the Company with
the Commission on August 16, 2021, March 28, 2022 and August 4, 2022, on or after the date that is 45 days after the Closing Date and
at a price per share equal or greater than the portion of the Per Share and Warrant Purchase Price allocable to one share of Common Stock
sold hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered
or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to such Transaction Documents. For clarification purposes, (a) this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the
Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Shares or otherwise and (b) participation in future offerings shall not be considered consideration under this
<U>Section 4.13</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such
time that the transactions contemplated by this Agreement are first publicly disclosed as described in <U>Section 4.5</U>. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company as described in <U>Section 4.5</U>, such Purchaser will maintain the confidentiality of the existence
and terms of this transaction and the information included in this Agreement, including the schedules hereto. Notwithstanding the foregoing,
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser
makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company
after the time that the transactions contemplated by this Agreement are first publicly disclosed as described in <U>Section 4.5</U>, (ii)
no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly disclosed as described
in <U>Section 4.5</U> and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company
to the Company or the Subsidiaries after the transactions contemplated by this Agreement are first publicly disclosed as described in
<U>Section 4.5</U>. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">ARTICLE
V.</FONT><BR>
<BR>
MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only
and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties,
if the Closing has not been consummated on or before September 30, 2022; <I><U>provided</U></I>, <I><U>however</U></I>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise
notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the
Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication
is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The
address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously disclose such information in accordance with applicable law and file such notice with the
Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, in the case of an amendment, by the Company and Purchasers which purchased a majority in interest of the Securities
based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived
provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any amendment effected in accordance with this <U>Section 5.5</U> shall be binding upon each Purchaser and holder of Shares and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties
of the Purchasers in <U>Section 3.2</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in <U>Section 4.8</U> and this <U>Section 5.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its affiliates,
directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such action or proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an action
or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under <U>Section
4.8</U>, the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities
for a period of two (2) years from the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>&nbsp;Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights <I><U>provided</U></I>, <I><U>however</U></I>, that in the case
of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to
any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company
for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the
defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I</FONT><U>ndependent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents or has
freely elected not to be represented by counsel after having been advised of the desirability to engage such counsel. For reasons of
administrative convenience only, each Purchaser and its counsel have chosen to communicate with the Company through the legal counsel
of the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement
Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company
and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision
contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the
Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Currency</U>. Unless otherwise stated, all dollar amounts and references to &ldquo;&lrm;&lrm;$&rdquo; in this Agreement refer
to the lawful currency of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I></I></FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&nbsp;<B>INTRUSION INC. </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 63%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 37%; font-size: 10pt"><U>Address&nbsp;for&nbsp;Notice:</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">By:__________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Name:&nbsp;&nbsp;Anthony
    Scott&nbsp;&nbsp;&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: &nbsp;&nbsp;&nbsp;President and Chief Executive
    Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">101 East Park Blvd.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">Suite 1200</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">Plano, Texas 75074</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">E-mail: Kimberly.Pinson@intrusion.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK, SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO INTZ SECURITIES
PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the undersigned have caused
this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%">Name of Purchaser:</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 41%; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><I>Signature</I>&nbsp;<I>of</I>&nbsp;<I>Authorized</I>&nbsp;<I>Signatory</I>&nbsp;<I>of</I>&nbsp;<BR>
<I>Purchaser</I>:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title of Authorized Signatory<BR>
(if not a natural person)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address for Notice to Purchaser:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>EIN Number or Social Security Number of Purchaser:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">DTC Participant Number (if applicable)</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">or other instructions for delivery of</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">Shares:</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="border-bottom: Black 1pt solid"><B>Maximum Subscription Amount ($):</B></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><B>$</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B><BR STYLE="clear: both">
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>intz-20220912.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOauOaaPty552mYkxvmRxfQkaHy4syWM2tiH8+9D2MdgL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:INTZ="http://intrusion.com/20220912" elementFormDefault="qualified" targetNamespace="http://intrusion.com/20220912">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://intrusion.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="intz-20220912_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="intz-20220912_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>intz-20220912_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>intz-20220912_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://intrusion.com/role/Cover" xlink:href="intz-20220912.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://intrusion.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
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::!LQGX@ @+VE $!]]]M/ !2#7<3[3B   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140081163050928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 12,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTRUSION
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000736012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">75-1911917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">101
    East Park Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
    1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Plano<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(972)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">234-6400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INTZ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>intrusion_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="intz-20220912.xsd" xlink:type="simple"/>
    <context id="From2022-09-12to2022-09-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
        </entity>
        <period>
            <startDate>2022-09-12</startDate>
            <endDate>2022-09-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-09-12to2022-09-12">0000736012</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-09-12to2022-09-12">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-09-12to2022-09-12">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-09-12to2022-09-12">2022-09-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-09-12to2022-09-12">INTRUSION INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-09-12to2022-09-12">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-09-12to2022-09-12">001-39608</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-09-12to2022-09-12">75-1911917</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-09-12to2022-09-12">101     East Park Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-09-12to2022-09-12">Suite     1200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-09-12to2022-09-12">Plano</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-09-12to2022-09-12">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-09-12to2022-09-12">75074</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-09-12to2022-09-12">(972)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-09-12to2022-09-12">234-6400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-09-12to2022-09-12">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-09-12to2022-09-12">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-09-12to2022-09-12">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-09-12to2022-09-12">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-09-12to2022-09-12">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-09-12to2022-09-12">INTZ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-09-12to2022-09-12">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-09-12to2022-09-12">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  2;RQ5?DD$V%X$   =$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V886_B.!"&O^^OL'*GTZ[4-G&@T/8 B5)ZAW:7L@U[>]K3?3") :M)G+4=
M:/_]C0--V%Z8@*H2)YDW3\:3UQ-Z6ZF>])IS0YZ3.-5]9VU,=N.Z.ESSA.D+
MF?$4CBRE2IB!H5JY.E.<1450$KN^YW7<A(G4&?2*?3,UZ,G<Q"+E,T5TGB1,
MO=SR6&[[#G5>=SR*U=K8'>Z@E[$5#[CYFLT4C-Q2)1()3[60*5%\V7>&].;6
MO[0!Q1E_";[5!]O$WLI"RB<[F$1]Q[-$/.:AL1(,OC9\Q./8*@''C[VH4U[3
M!AYNOZK?%S</-[-@FH]D_$U$9MUWKAP2\27+8_,HMW_R_0T5@*&,=?&?;'?G
MMML."7-M9+(/!H)$I+MO]KQ/Q&& =R3 WP?X!??N0@7E'3-LT%-R2Y0]&]3L
M1G&K133 B=3.2F 4'!409P8CN>&JYQJ0LCO<<!]VNPOSCX0%/+L@U#\CON?[
M/X>[0%!B^"6&7^BU, SRSW"AC8*)^K>.:*?0KE>PU7NC,Q;RO@/EJ;G:<&?P
MVR^TX_V.\+5*OA:F/KB380ZU:,C\)>-U<'CXU?E'!*)=0K11E2$01 7%?<Q6
M=11X_)+%FB,<ER7'Y6G)F'$E9$3&:42@^&KS@BN59=141YT2K8,*CE,CS NY
M%S$GTSQ9U-<VKN%Y]+QUW?&N$)YNR=,]A>>1KX2M;,C9E"6UB<)U)M/YX]=@
M\C!]-YF.+A"PJQ+LZA2P$4RC8C&9I!%_)A_Y2QT:KN3!I]OJ>!2;O^L2Z_H4
MK#E[)I,(V,12A*RP[^.SB2MV+\_I-86_+H)'O<HNO5, )VDH5295P79& @/E
M3Z0B(YE#0B&O,JJ=Y0;UNS$&>>#I]!3(812!$^JSUPWR"<XC#VD]&2Y)/?J.
MP&?,-#SW3#V1VW@38;25]5/4N7':^5;6TN*202X,+W@IM"<89;4 4-S"WU*.
M[ AF?"ZW:2TA+C>+62HQL&I1H+BKOP4K:W&FY$:D8?ULXYKSOS&T:IV@N+V_
M19M);<!LOHOL^ ."*W8OO6X;8ZL6"HJ[?#%_0VADCZ/@ N^ON_X'#*5:(RAN
M[I]D"%F9K66*+5H-(GZK?=YIX\5>+0X4]_1O2AC#4TA-DN3IWH)U+14NU-1R
MT&IAH+B/!S(6H3 B79'/4.!*L+B6!U=IXO&KA<#'K7JF^'D(Z>'PA.TZ0VC.
MH(=]6"[KYZ]!KY&L<G\?M^K_D4VTSH&L$1"7;00\Z/5Q=YX+ ^V97((YOU]\
M( $/<ZBWVM:C0<G6)_0&@9'ATQGYU;OP*,F8(AL6YYQD<+=ZS11*72T /N[8
M<\4B6WW!2[*0M;77(  ]W'>,I')\'W?GUX21\7.X9NF*'VTJ&X2FP^!N^ 5C
MJJS>/\GJQPE7*YNE/T#!K*V!9"RMGUI<\&BYN0<ON_:'@\_,7E&3F"]!R+OH
M@J[:O8OO!D9FQ?OO0AIXFRXVUYS!HV!/@.-+*<WKP+Y2E[^(#/X#4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ $F\L59E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M"  2;RQ5?DD$V%X$   =$0  &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ $F\L59^@&_"Q @  X@P   T
M             ( !H@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  2;RQ5
MEXJ[',     3 @  "P              @ %^#P  7W)E;',O+G)E;'-02P$"
M% ,4    "  2;RQ5JL0B%C,!   B @  #P              @ %G$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ $F\L520>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ $F\L5660>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="intrusion_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://intrusion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="intrusion_8k.htm">intrusion_8k.htm</File>
    <File>intrusion_ex0401.htm</File>
    <File>intrusion_ex0501.htm</File>
    <File>intrusion_ex1001.htm</File>
    <File>intz-20220912.xsd</File>
    <File>intz-20220912_lab.xml</File>
    <File>intz-20220912_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "intrusion_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "intrusion_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "intz-20220912_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "intz-20220912_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "intz-20220912.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "INTZ",
   "nsuri": "http://intrusion.com/20220912",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "intrusion_8k.htm",
      "contextRef": "From2022-09-12to2022-09-12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://intrusion.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "intrusion_8k.htm",
      "contextRef": "From2022-09-12to2022-09-12",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001683168-22-006313-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-006313-xbrl.zip
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M@_O\#!SJ]FAD"#QV(<AR 5Q%P*U#:UUW2'/DF/:,\0!4=.?(A9U^%[\C&6D
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M!.BUNQ/8:_1+% Z*[P%USY16W6(NJ@(-!$($XA]@#3/+DM2I@35/Y@Q-6X&
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M9"<&5JNA!$[2$LD'E\7@9)*Y[5YX,B'4D<.M"18ZD-0\(;K"HRUC8$W$#6?
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M&^2]<1AWA\:*)JA'%63P0K=^@,ND2$PF)2[&Y3()H?++*'1#WH#6?"OKIS
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M*5:/)91H78-/&VT[S_5?@@*=*KW&G0Q::GR35.;U&\:=V7DX5:&\Z<FG<9*
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MOK,D*)2DHZB^<P(CWE[QS%7D'5V+NIL^!##DRM,X3_^K GGB"9'/.A#GC*+
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M(1-CA'ZY._W^=WVR27#WSM7[W@;EUQ[>NW1>;2>D-&ZN6[(75V=-40JB9VA
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M=U%M7^%POZ0.YN'7?YZ^.STYPTF(8;:GO\%\14TY'N%TP6Y=\L3/RF*>H1S
MDJ1-!-N\N82EBD@DG2#23V'IZW52X%W@[RA=+'@)HBJ]R.I&Q*EN0$CIFC6,
MJ:+5,?)_ J.8)/5X-$\760&R,TWS\OH A1IN2S^^! GEP>&?OR85Z)\&Y@3_
M$NF,YFF=X:_@FJRNURG]O$[S'#\A075R$$=.>,UG=7J55DF>;UB@BK*)?BNS
MHLDWL;VYBGNTJ,JE'0'>P;T4;$<[.'B790F[8+&&^^/=9E4VA5?M3.NMR,:M
M2N7K-[_"W5 T7[QY=QI'+U]'S]Z\/GOY_/3=R?G+-Z]17,<CF<_ENEDG.8CH
M55J@"*"P-@E)36<J>95!?*,2+JVBB[*<TT=72;Y.ICGJO*(&G25BBO>OTEF:
MK5BXDWGZ^SJ9;7 MKR\S$!:0PO$(5=@45G3VOBBO\W1^D<Y#0>S*5I3@F% (
M%J"ERNOZNW_+J1P<O>WYOGF=_[W/_O[%F]?G]H$/KE,T?;Z#C58MD_QO/YR\
M.W_Y[!78!B]!->.O03K>D?6%__O\],7+UR]1(,[V:XL<@378F;M%LLSRS7<W
M/9-^6V?_2GF(^AJ?ZG]EF9ZCWN83XQ ,"]@X?'ZH^N:C1;5[FM?I-6ZBOAV+
MNQ54,"K955FK'@U_@[?D?826 ]T<=F4"IPYIB#0IX/.^LPMM43R?8&0XJ6!X
M#N[#OZ8H&7MRL<CR#([EP(["N<-C=A.]!6.)5&("$SZ'HV\&QV $BP-WU+^:
MRZI<7UR"J9?B-W2^9;C]E^D\2ZH,!XSJN2KSFBZM]<\<#_F-?,8VP:Q<+N&!
M\H/QZ#J#A4MT' E9AY=JI,"#UC6K?#%8P-98PP=\KW=KT.V/'SX9-#?VS/0S
MR[YN+LLJ^Q<=>,'2UY>X[=J[""9>#!78RFX%<-[-7GIT>#1Y__X ]]/>3NR/
M95+-45D]I]U1!JZ&;BR<V*G^<*X_;)F*^SN%X)@6X/]%SY/-@%::)QNQY4 Q
M%=$9>I;P&0P"=GI""H6_IC\*L=I0M:35+ .[<9H4[VL4WW.<\*PAVP[?Z7_*
MZCWIE41V"+JP%9B#OZ]AG5!;C4?@*.,VJ-(E&)S1+(?S:?XT^OXEQCA657D%
MEN2<HQDOP;_BSR_+:_0J_,=XP,URT(Z+;$:[,.Z.C_<B^A_3%(Y-./9H_TWM
MZ, B#H87]8TNFH,;!!_*)(,?!M9I$UV6RU1F-W;?7:8Y[&U8G@>K/)EUOB_*
MX@$L#OKW,,YTN<K+39JZ-<)CN]#%J3,P3A)8BPK4;\WS" HZF[%36;)*QB%B
M8 !6 "]=76YJF!*8 _#M8-7RDN>GQA'C[WG#H,*1*R[ ":@*M G@*IF9!M:I
M+N%BTEUT78IA@:HLLAEX7\4</J3@%8YS4X-?6D<3'X? Y;F&![D?U0?XN)U%
MZ"(MG ^)[[9*"[HG'%>X2#/8"C#Y."D%ZU.0U+W=\<]  F#2!S3EC+]5]>C<
M;G+KDSS5+\S1;L,1YH Z9F-OW^<9%&O+WOL3A_[>SREHA*RNVV:4%]]?P"."
M*3S#V%<0[D7Y/?T LEQ<T*$OM]GKF02!.FO*V?N!N:PY_B>*F"**\..6X11'
M__'P\.%1M(*3!R,\H#)0QU_2J8[A''<^P?E;T]U,O X<EU+L!1)Y_Q4,!(Y-
M=%B3!6P$/(;A(,);2*0;;DB+.;]?0ER54[!)8/[AEWTV,*["<)A43(.S];3.
MQ(>41;DNU_D\0O.CR5E;79:Y>'=5BK<IHV1&YA :#'BS!MXRLD,S"8>8/<QR
MW40Y6"N-F&(<1YZ"S[NJ4CC]T;:J^5+*T\5PHO,OKSD&[4W.C'Q0BG*CUXR>
MK1T'^*A@K309AAU)UN#"] /:%#6&(LF"2D4K4&P2K(;8W?TZ@X-/7KX>>'L*
M75ZE<?#*^RR2)%'/RG51IWF/)/Z:Y1A:.,,8<)%%/Y7EO$))^WNR7#V%8=4@
M$W'T]O#9OLWA_9,_9P)$G_F_'CR(7F1I/O\N>IM<I$_AQK^OTV*&H=OHP0,!
M*7S__.7_"U/]#YIR]5WT]:K1,3R8E@TX&?+9E)PP]]F/X-N]CXY@D'699W-X
M_OG)CZ].HV>GKUZ]/7G^_.7KG_[/WQ[^C?X^>WOR3/^61\K=,->:K&H8FO[K
M*7A-\^82Y^KA?_;$G;\_?Z?W(#4(CIY.#XP_G*\\7= 5S_4*N?6C1__I5^K\
M>=\O'O_G  K!S*[.Z]/H?+." 9Y4R32;/8U>)\N4Y_YUB1-^9"_Z2J_";X:>
M_JCU=(%VV"%_=?X._P?G'/X+B]FSKE.P--X_F*9P L" 5B0,.ZPUO.4*#JM-
MGAH4",7\__?1UP_A^:OPB?;M\*U9R/9EW_F3XO3Y3R?O!@Q/;Y[_O:HI3!*=
M^G "^%-)]%."9S":%-%)D>2;.F,3_UW:@/D"AE!T1F&&?3M%_/P65QG,E\1I
M7B77GS+N7.YWV/F44MDT&Y_2N<>9;?9\9M5#/YDU \K!^/3VU^C3'/WCT>,8
M Y!PIL 3YK'#KE3K7&( 57JQSB7$N:K*Y3J_("P7F?24N=JSR;_M!4^7</'+
M&B.(L[Z\*"Y?)E_C(D^2 Q.9"!U-=A-K[QZ*S[MY,$TP,#\#]R0MZD33Y!I0
MAS<J%XMLEE9U[%-$E$>MUWF#D!<.ML^OLKJ;/&H!LC8:**'11*L<)ZY<%MET
M75.,_(%L?K23$+:%O\ Q:P2?G-P+QF[-U_D&G@OW2@E5 QIFS>@_S-3'&-Y.
M8!U^HRB\CHO2!O)NH((0G.C&W,V9D</;O8FY+J$(4-8T*2V!O?UXY%-J:=V
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M-&NJ#*_%HJ-"'L+8[T0?<;],]6YUM+Y\]M%]^>P?GW62\QNYM((X5T^%7=>
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MO-LV+.P<V:U><W'&$-(TVQA7B3UJ1LXD4\37.$B8D'&+8\UT*"UPE'N"![N
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M2'(A+0$<T">:N @R61>.-NH :99J6$!:"&Z[R584G=.7X'+#X\6@%\,T-JJ
M4^"E8$]Z6$G:^A%,:MCVA>C\:W@ S26B"?I<B$B5&$:@.7^N.Z<-?:&,0]3
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M!%*5H:HM#CT4[3.JTT0L Z34;%9#0H_SP56*O5IA7P&W\>3&L,6!>HD["'T
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M='ROZW17K4040=<B&&N3Y%2GS 5_$!CI!N5"8'"Y%!WE&[TFG2/WZ79%W:L
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MPH3Z%$AJ8V\T6\3ZAY2@TDRB "GE!\TPQDZ6,J99$_PW)=8HBX%XA4J;=)L
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MCJ<;+847$YNJ;>2E;AJ&$=^;1D*QMC9$FJE>NO.P9R?R/CYY)QS8M_<XL-O
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ML?.SLMG_<G#R]C-!=S^,/AZ]^7]02P,$%     @ $F\L5?*W-_DJ P  K@L
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MB<\/P;SLAX8]H M6@Z]K@;J3J^GE'U!+ P04    "  2;RQ5<I3DWOX*  "
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M/U!+ 0(4 Q0    ( !)O+%55T<Q=A!8  .=U   0              "  0
M  !I;G1R=7-I;VY?.&LN:'1M4$L! A0#%     @ $F\L5;E:BFLX00   :H!
M !0              ( !LA8  &EN=')U<VEO;E]E># T,#$N:'1M4$L! A0#
M%     @ $F\L58O<4HYL#@  ^D4  !0              ( !'%@  &EN=')U
M<VEO;E]E># U,#$N:'1M4$L! A0#%     @ $F\L58*;6@BVD0  *)P# !0
M             ( !NF8  &EN=')U<VEO;E]E>#$P,#$N:'1M4$L! A0#%
M  @ $F\L5?*W-_DJ P  K@L  !$              ( !HO@  &EN='HM,C R
M,C Y,3(N>'-D4$L! A0#%     @ $F\L57*4Y-[^"@  @(8  !4
M     ( !^_L  &EN='HM,C R,C Y,3)?;&%B+GAM;%!+ 0(4 Q0    ( !)O
M+%4<?UMR5@<  -=7   5              "  2P' 0!I;G1Z+3(P,C(P.3$R
>7W!R92YX;6Q02P4&      < !P#) 0  M0X!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
